{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/continuous-innovation-delivers-faster-more-efficient-clinical-trials#webpage",
"url": "https://www.fortrea.com/insights/continuous-innovation-delivers-faster-more-efficient-clinical-trials",
"name": "Continuous innovation delivers faster, more efficient clinical trials",
"description": "This Fortrea white paper explores operational considerations affecting dry eye clinical trials across evolving ophthalmology research environments. The content focuses on dry eye clinical trials, study design considerations, endpoint selection, patient variability, ophthalmology clinical research planning, and operational challenges associated with dry eye studies. The white paper highlights considerations related to patient symptom variability, endpoint consistency, trial design complexity, study execution planning, and operational factors affecting ophthalmology clinical research programs. Fortrea discusses clinical and operational perspectives designed to support dry eye clinical trial planning, strengthen study design approaches, and address execution considerations associated with ophthalmology research environments. By integrating study design understanding with endpoint planning and operational considerations, the white paper provides insights into operational considerations affecting dry eye clinical trials and broader ophthalmology clinical research programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Continuous innovation delivers faster, more efficient clinical trials",
"item": "https://www.fortrea.com/insights/continuous-innovation-delivers-faster-more-efficient-clinical-trials"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/continuous-innovation-delivers-faster-more-efficient-clinical-trials#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/continuous-innovation-delivers-faster-more-efficient-clinical-trials#webpage"
},
"headline": "Driving Faster and More Efficient Clinical Trials Through Continuous Innovation | Fortrea White Paper",
"description": "This Fortrea white paper explores operational considerations affecting dry eye clinical trials across evolving ophthalmology research environments. The content focuses on dry eye clinical trials, study design considerations, endpoint selection, patient variability, ophthalmology clinical research planning, and operational challenges associated with dry eye studies. The white paper highlights considerations related to patient symptom variability, endpoint consistency, trial design complexity, study execution planning, and operational factors affecting ophthalmology clinical research programs. Fortrea discusses clinical and operational perspectives designed to support dry eye clinical trial planning, strengthen study design approaches, and address execution considerations associated with ophthalmology research environments. By integrating study design understanding with endpoint planning and operational considerations, the white paper provides insights into operational considerations affecting dry eye clinical trials and broader ophthalmology clinical research programs.",
"genre": "White Paper",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-02-04",
"dateModified": "2025-02-04",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-02/continuous-innovation-delivers-faster-efficient-clinical-trials.pdf",
"encodingFormat": "application/pdf"
}
}
]
}